Table 6.
Subgroup Analysis by Study Design
| Design | Lymphomas | Patient-Years | NHL rate per 10,000 pt-years | SIR* | 95% CI |
|---|---|---|---|---|---|
| RCT | 2 | 3860 | 5.2 | 2.6 | 0.19–35.7 |
| Cohort | 7 | 15,192 | 4.6 | 2.3 | 0.44–22.7 |
| Case series | 4 | 2125 | 18.8 | 9.4 | 1.35–104.0 |
SIR compared with SEER.
Subgroup Analysis by Study Design
| Design | Lymphomas | Patient-Years | NHL rate per 10,000 pt-years | SIR* | 95% CI |
|---|---|---|---|---|---|
| RCT | 2 | 3860 | 5.2 | 2.6 | 0.19–35.7 |
| Cohort | 7 | 15,192 | 4.6 | 2.3 | 0.44–22.7 |
| Case series | 4 | 2125 | 18.8 | 9.4 | 1.35–104.0 |
SIR compared with SEER.